Literature DB >> 6714571

Nonalcoholic cirrhosis associated with neuropsychological dysfunction in the absence of overt evidence of hepatic encephalopathy.

R E Tarter, A M Hegedus, D H Van Thiel, R R Schade, J S Gavaler, T E Starzl.   

Abstract

Although much is known about the neuropsychological functioning of cirrhotic individuals with Laennec's (alcohol associated) cirrhosis, little is known about the neuropsychological functioning of individuals with nonalcoholic cirrhosis. In the present investigation, we have determined that individuals suffering from chronic nonalcoholic cirrhosis, despite the absence of clinical signs of hepatic encephalopathy, are impaired on neuropsychological tests that measure visuopractic capacity, visual scanning, and perceptual-motor speed. In contrast, intellectual, language, memory, attentional, motor, and learning abilities are intact. In comparison with a chronically ill control group of patients suffering from Crohn's disease, individuals with advanced nonalcoholic cirrhosis exhibit less emotional disturbance, but are more impaired in their daily activities. These findings indicate that individuals with nonalcoholic cirrhosis, even in the absence of overt clinical signs of encephalopathy, manifest neuropsychological impairments and experience significant disruption in the routines of everyday living.

Entities:  

Mesh:

Year:  1984        PMID: 6714571      PMCID: PMC2963938     

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  12 in total

1.  Effect of experience and amount of information on identification of cerebral impairment.

Authors:  S G Goldstein; R A Kleinknecht; R E Deysach
Journal:  J Consult Clin Psychol       Date:  1973-08

2.  A controlled clinical trial of lactulose in hepatic encephalopathy.

Authors:  F Simmons; H Goldstein; J D Boyle
Journal:  Gastroenterology       Date:  1970-12       Impact factor: 22.682

3.  Surgical exclusion of the colon for chronic hepatic encephalopathy.

Authors:  S J Dudrick; J A Mackie; O Serlin
Journal:  Am J Surg       Date:  1968-01       Impact factor: 2.565

4.  Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism.

Authors:  L Rikkers; P Jenko; D Rudman; D Freides
Journal:  Gastroenterology       Date:  1978-09       Impact factor: 22.682

5.  Chronic hepatic encephalopathy. A psychometrical study.

Authors:  S Rehnström; G Simert; J A Hansson; G Johnson; J Vang
Journal:  Scand J Gastroenterol       Date:  1977       Impact factor: 2.423

Review 6.  Brain damage in chronic alcoholism: a neuropathological, neuroradiological and psychological review.

Authors:  M A Ron
Journal:  Psychol Med       Date:  1977-02       Impact factor: 7.723

7.  WAIS functioning of cirrhotic and non-cirrhotic alcoholics.

Authors:  H H Smith; L S Smith
Journal:  J Clin Psychol       Date:  1977-01

8.  Method for measuring cerebral dysfunction in patients with liver disease.

Authors:  R Zeegen; J E Drinkwater; A M Dawson
Journal:  Br Med J       Date:  1970-06-13

9.  Psychomotor performance defects in cirrhotic patients without overt encephalopathy.

Authors:  S J Gilberstadt; H Gilberstadt; L Zieve; B Buegel; R O Collier; C J McClain
Journal:  Arch Intern Med       Date:  1980-04

10.  Encephalopathy in patients with cirrhosis of the liver. A neuropsychological study.

Authors:  P Elsass; Y Lund; L Ranek
Journal:  Scand J Gastroenterol       Date:  1978       Impact factor: 2.423

View more
  40 in total

Review 1.  Psychiatric aspects of portal-systemic encephalopathy.

Authors:  J Wiltfang; W Nolte; K Weissenborn; J Kornhuber; E Rüther
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

2.  Correlations between cerebral glucose metabolism and neuropsychological test performance in nonalcoholic cirrhotics.

Authors:  Alan H Lockwood; Karin Weissenborn; Martin Bokemeyer; U Tietge; Wolfgang Burchert
Journal:  Metab Brain Dis       Date:  2002-03       Impact factor: 3.584

3.  Helicobacter pylori infection is not associated with subclinical hepatic encephalopathy in stable cirrhotic patients.

Authors:  I A Scotiniotis; M R Lucey; D C Metz
Journal:  Dig Dis Sci       Date:  2001-12       Impact factor: 3.199

4.  Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy.

Authors:  R K Dhiman; M S Sawhney; Y K Chawla; G Das; S Ram; J B Dilawari
Journal:  Dig Dis Sci       Date:  2000-08       Impact factor: 3.199

Review 5.  Positron emission tomography in the study of hepatic encephalopathy.

Authors:  Alan H Lockwood
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

Review 6.  Pathogenesis and treatment of portal-systemic encephalopathy: an update.

Authors:  R F Butterworth
Journal:  Dig Dis Sci       Date:  1992-03       Impact factor: 3.199

7.  Acute and chronic hyperammonemia modulate antioxidant enzymes differently in cerebral cortex and cerebellum.

Authors:  Santosh Singh; Raj K Koiri; Surendra Kumar Trigun
Journal:  Neurochem Res       Date:  2007-08-04       Impact factor: 3.996

Review 8.  Characteristics of minimal hepatic encephalopathy.

Authors:  Piero Amodio; Sara Montagnese; Angelo Gatta; Marsha Y Morgan
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

Review 9.  Hepatic encephalopathy: a dynamic or static condition.

Authors:  Charmaine A Stewart; Jane Cerhan
Journal:  Metab Brain Dis       Date:  2005-09       Impact factor: 3.584

10.  Attention dysfunction in cirrhotic patients: an inquiry on the role of executive control, attention orienting and focusing.

Authors:  Piero Amodio; Sami Schiff; Franco Del Piccolo; Daniela Mapelli; Angelo Gatta; Carlo Umiltà
Journal:  Metab Brain Dis       Date:  2005-06       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.